“…Where indicated, the following inhibitors were used: 4-AP (2 mM, SigmaAldrich), (S)-(-)-Blebbistatin (30 M, Toronto Research Chemicals, ON, Canada), U0126 (10 M, Promega), PF573228 (20 M, TOCRIS Bioscience, Ellisville, MO), and aGA (50 M, Sigma-Aldrich). It should be noted that aGA has been reported to efficiently block gap junctions in MDCK cells (Abraham et al, 1999;De Blasio et al, 2004). LY294002, ML-7, and Y27632 were from Calbiochem (Darmstadt, Germany) and were all used at 10 M.…”